NCT01155947

Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fasting Conditions

An Open Label, Balanced, Randomized,Two-Treatment, Two-Sequence, Two Period, Crossover, Single Dose Comparative Oral Bioavailability Study Of Anastrozole Tablets 1 mg (Test) Of Dr. Reddy's Laboratories Ltd., India And ARIMIDEX® Tablets 1 mg (Reference) Of Astrazeneca Pharmaceuticals LP, USA In Post Menopausal Healthy Women Subjects Under Fasting Conditions.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 36 (actual)
• Sponsor: Dr. Reddy's Laboratories Limited · Industry
• Sex: Female
• Age: 37 Years – 67 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare bioavailability in healthy, post menopausal women subjects under fasting conditions.

Detailed description

Open label, balanced, randomized, two treatment, two-sequence, two periods, crossover, single dose, comparative oral bioavailability study in healthy, post menopausal women subjects under fasting conditions.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Anastrozole	Anastrozole Tablets 1 mg of Dr.Reddy's Laboratories Limited

Timeline

• Start date: 2008-05-01
• Primary completion: 2008-06-01
• Completion: 2008-07-01
• First posted: 2010-07-02
• Last updated: 2010-07-02